Published on British Columbia Drug and Poison Information Centre (BC DPIC) (http://www.dpic.org)

Home > Chewing the fat about hCG and weight loss

Chewing the fat about hCG and weight loss

Access: 
professional
Article type: 
drug information

Introduction

A pharmacist calls the BC Drug & Poison Information Centre about a patient who is presenting with a prescription written by a naturopath for hCG 200 IU SC daily. The patient says it's for weight loss and is asking about side effects. The pharmacist wonders if hCG is indicated for weight loss and if naturopathic physicians are allowed to prescribe it?

 

What is hCG?

hCG (human chorionic gonadotropin) is a glycopeptide hormone produced by the human placenta and excreted in the urine of pregnant women.1 It is essential for early maintenance of the corpus luteum during pregnancy and for normal development of testes in the male fetus.

 

Theory in weight loss

The concept of using hCG for weight loss dates back nearly 60 years when British endocrinologist Albert Simeons advocated the use of low dose chorionic gonadotropin injections (125 IU daily for six days per week) as an adjunct to a very low calorie diet (500 kcal daily) for the treatment of obesity.2 He observed weight loss and body fat redistribution in males treated with hCG for a hypogonadal disorder called Frolich's syndrome and he theorized that the same would be observed in patients with "simple obesity." He proposed that hCG helped patients tolerate the low calorie diet by reducing hunger and weakness, and in 1954 he reported that over 500 patients had successfully lost 20 to 30 pounds using his method.

 

Evidence for effectiveness

Simeons' method has been controversial from the beginning. A 1969 editorial on the subject called for additional study and questioned the role of hCG as a weight loss therapy.3 In 1995, a meta-analysis of eight uncontrolled and 16 controlled trials examining the effects of hCG in the treatment of obesity concluded there was no scientific evidence that hCG brought about weight loss or fat redistribution, nor did it reduce hunger or induce a feeling of well-being.4 Nevertheless, Simeons' method continues to be promoted in the popular media and by alternative medicine practitioners. A recent commentary suggests that Simeons' observations in patients with Frolich's syndrome were misinterpreted and that weight loss observed in patients with simple obesity is due to the low calorie diet and nothing else.5

 

hCG products and possible adverse effects

Currently, there are three injectable hCG products in Canada. Chorionic Gonadotropin for Injection® and Pregnyl® are both available in unreconstituted 10,000 unit vials and derived from the urine of pregnant women.6,7 Ovidrel® is derived from recombinant DNA and is available as choriogonadotropin alpha measured in micrograms.8 These products are indicated for the treatment of female infertility and selected hormonal disorders in men. Serious adverse effects are a possibility and the U.S. Food and Drug Administration (FDA) has received reports of depression, pulmonary embolism, cerebrovascular events, cardiac arrest, and death associated with the use of "off-label" hCG injections.9 Several homeopathic hCG preparations intended for oral administration may also be available but these are not expected to be pharmacologically active and are considered "illegal" by the FDA.

 

Recommendations

Naturopathic physicians are restricted from prescribing choriogonadotropin alpha (Ovidrel®) but, for reasons that are not clear, the same restrictions do not apply to the other injectable hCG products.10 Hence, whether pharmacists dispense prescriptions for injectable hCG intended for  weight loss comes down to a matter of ethics. Given the lack of evidence showing efficacy and the potential for serious adverse events, pharmacists may choose not to fill such prescriptions. Pharmacists choosing to dispense prescriptions for injectable hCG should ensure their patients are informed of the risks.

 

by Rob Gair, BSc (Pharm), CSPI

 

References

  1. Parker KL, Schimmer BP. Pituitary hormones and their hypothalamic releasing hormones. In: Brunton LL, Laxo JS, Parker KL, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. Toronto: McGraw-Hill; 2006 p:1489-510.
  2. Simeons, AT. The action of chorionic gonadotropin in the obese. Lancet. 1954;267:946-7.
  3. Albrink MJ. Chorionic gonadotropin and obesity? Am J Clin Nutr. 1969;22:681-5.
  4. Lijesen GK, Theeuwen I, Assendelft WJ, Van Der Wal G. The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis. Br J Clin Pharmacol 1995;40:237-43.
  5. Toffle RC. "There they go again" - hCG and weight loss. W V Med J. 2011;107:12-3.
  6. Pharmaceutical Partners of Canada. Chorionic Gonadotropin for Injection, USP. Package Insert. Richmond Hill, ON; 2008. Available from: http://ppcdrugs.com/en/ products/product_inserts/EN_WebInsert_ChorGonad.pdf
  7. Merck Canada Inc. Pregnyl® Package Insert. Kirkland QC; 2011. Available from: http://www.merck.ca/assets/en/pdf/products/PREGNYL-PM_E.pdf
  8. Repchinsky C, editor. Compendium of pharmaceuticals and specialties. 2012 ed. Ottawa: Canadian Pharmacists Association; 2012.
  9. U.S. Food and Drug Administration. Questions and answers on HCG products for weight loss [updated 2011 Jun 12; cited 2012 May 25]. Available from : http:// www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/ MedicationHealthFraud/ucm281834.htm
  10. College of Naturopathic Physicians of British Columbia. Scope of Practice for Naturopathic Physicians: Standards, Limits and Conditions for Prescribing, Dispensing and Compounding Drugs. Vancouver, BC 2010. Available from : http:// www.cnpbc.bc.ca/Policies-and-Procedures.html?reload

©2012 B.C. Drug and Poison Information Centre

 

A version of this document was published in BCPhA's The Tablet. 2012; 20(9): 26-27.

 


We are grateful to all the First Nations who have cared for and nurtured the lands and waters around us for all time, including the xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh Úxwumixw (Squamish Nation), and səl̓ílwətaʔ (Tsleil-Waututh Nation) on whose unceded and ancestral territory our centre is located.


© 2024 BC Drug and Poison Information Centre

All material found on the BC Drug and Poison Information Centre (DPIC) website is provided for informational purposes only. It is not meant to replace the expert advice of a healthcare professional such as a physician, pharmacist, nurse or qualified poison specialist. Use of this site is governed and restricted by specific terms of use. Please review the full terms and conditions below prior to using the DPIC website. In the event of a poisoning emergency, call your local poison control centre immediately. Portions of this web site are intended for healthcare professionals. Interpretation and application of information may require more detailed explanation than contained herein, particularly regarding any clinical information that is found in or linked to this site. Patients are advised to consult their health care provider regarding diagnosis and treatment, and for assistance in interpreting these materials and applying them in individual cases.
Terms and Conditions
Source URL (retrieved on 2025-04-18 18:59): http://www.dpic.org/article/professional/chewing-fat-about-hcg-and-weight-loss